Excalipoint Therapeutics Announces Clinical Trial Collaboration with Roche to Evaluate EXP011 in DLL3‑Expressing Solid Tumors
Roche to supply atezolizumab (Tecentriq®) for use in Excalipoint’s future studies investigating the combination of EXP011 (CTM012) and…